Table 2 The pooled estimates of novel coronavirus complication among COVID-19 patients
From: The effect of age on the incidence of COVID-19 complications: a systematic review and meta-analysis
Complication of COVID-19 | No. of studies | Sample size (N) | Pooled incidence (95%CI) | Heterogeneity (I2, P value) | Egger’s P value |
|---|---|---|---|---|---|
ARDS | 12 | 3064 | 30.93 (21.26, 40.60) | 99.05%, < 0.001 | 0.38 |
AKI | 10 | 2328 | 7.14 (3.84, 10.44) | 91.31%, < 0.001 | 0.13 |
ACI | 14a | 1215 | 6.38 (−2.84, 15.60) | 95.08%, < 0.001 | 0.038 |
Shock | 10 | 2874 | 10.89 (7.42, 14.35) | 98.01%, < 0.001 | 0.29 |
ALI | 6 | 1823 | 22.77 (14.05, 31.48) | 94.58%, < 0.001 | 0.39 |